Astena Holdings Co., Ltd. (TSE: 8095)
Health Care · Pharmaceuticals · JP
¥538.00
-0.19% today · +5.3% 1Y
Astena Holdings Co., Ltd. (TSE: 8095) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $136.82M and employs 1,543 people.
Over the last twelve months the share price has gained 5.3%, trading between 456.00 and 544.00.
Tweenvest scores Astena Holdings Co., Ltd. across four factors: quality 69/100, value 64/100, growth 47/100, dividend 90/100. Its strongest factor is dividend.
8095 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $136.82M
- Revenue (TTM)
- $422.22M
- P/E
- 9.38
- EPS
- 57.37
- Dividend yield
- 3.35%
- Beta (5Y)
- -0.05
- 52-week high
- ¥544.00
- 52-week low
- ¥456.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.43M
- Employees
- 1,543
- Next earnings
- —
About Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd., a Japanese company founded in 1914 and based in Chuo, is engaged in the development and distribution of a wide array of healthcare and chemical products. Its Fine Chemical division specializes in manufacturing and selling active pharmaceutical ingredients (APIs) and vital medical supplies used in treatments for fever reduction, pain relief, inflammation management, and blood vessel constriction. The Medical division focuses on biotechnology-related activities, providing support services for drug development and distributing essential medical equipment. The Health & Beauty Care, and Food segment is responsible for marketing non-prescription medications, raw materials for food and functional food products, and cosmetic ingredients. This division also manages direct-to-consumer sales through online and mail-order platforms, alongside offering contract manufacturing services for cosmetic items. Additionally, Astena Holdings' Industrial Chemicals division produces and supplies specialized chemicals for surface treatment and other industrial applications, serving sectors such as printed circuit boards, electronic devices, general plating processes, and semiconductors. The company, initially known as Iwaki & Co., Ltd., officially adopted the name Astena Holdings Co., Ltd. in June 2021.
- ISIN
- JP3150000002
- Founded
- 1914
- Listed since
- Jan 1, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.